Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sprout Project: Antiviral Treatment for Pediatric Chronic Hepatitis B
NCT05792761Recruiting
- Start
- May 2021
- Primary completion
- Dec 2025
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
Open-label trial of peginterferon alfa-2b in hepatitis B (HBV) (3 arms). Primary endpoint: Clinical cure rate. Started May 2021; status: recruiting.
02
Drugs
peginterferon alfa-2b
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT05792761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05792761.